FDA reviews Johnson & Johnson booster shot next week
Johnson & Johnson says that the booster of their vaccine, if given two months after getting the first shot, provides 94% protection against symptomatic disease. WATCH FULL EPISODES OF WORLD…
Oxford-AstraZeneca trial shows its vaccine is 79% effective
Oxford-AstraZeneca’s new trial data shows high efficacy against symptomatic COVID-19. source